The University of Queensland’s Diamantina Institute received a $10 million grant for melanoma research. Part of this money will be used to install 15 Canfield Scientific VECTRA WB360 whole body imaging systems across Queensland, New South Wales and Victoria as part of the establishment of the ACRF Australian Center of Excellence in Melanoma Imaging and Diagnosis. The center will combine the 3D imaging technology of the VECTRA WB360 with a telemedicine network to improve early detection of melanoma.
The VECTRA WB360 3D imaging system works by capturing a 3D total body image in milliseconds, significantly improving lesion surveillance and patient comfort, while reducing appointment times and healthcare costs. It is estimated that each of the 15 VECTRA WB360 systems will be able to provide 3,000 examinations per year, resulting in approximately 100,000 captures within three years—a significant boost to the healthcare system’s current capacity.
“Melanoma is Australia’s national cancer with Australians experiencing 12 times the global incidence. It is the most common cancer in Australians aged 15 to 40,” said Professor H. Peter Soyer, director of the Dermatology Research Centre at the University of Queensland. “Early detection is the key to saving lives and to achieving our vision of a world without melanoma.”
